PEGylated Liposomal Nanocarriers in Cancer Therapy: Emerging Strategies and Clinical Prospects.
INTRODUCTION Nanomedicine has changed the course of oncology through drug-delivery systems that improve efficacy while reducing systemic toxicity. PEGylated liposomes have specifically revolutionized cancer treatment by enhancing pharmacokinetics, stability, and tumor-selective deposition via the enhanced permeability...